transdermal ozone associated with lower blood glucose and urea levels during chemotherapy
Ozone therapy reduced blood glucose levels (from 5.3±0.22 to 4.0±0.15 mmol/L) and urea levels (from 5.8±0.14 to 4.3±0.18 mmol/L) in breast cancer patients on chemotherapy, while control patients showed increases in both parameters.
What this means for you
Blood glucose and urea are two markers your body works hard to keep in balance — especially under physical stress. When ozone exposure was associated with keeping both in a healthier range, that suggests the body may be managing metabolic load more efficiently. For anyone focused on recovery and resilience, that kind of internal balance matters.
The published research
Ozonetherapy in a Complex Treatment of Breast Cancer
· 1980
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.